Vetoquinol Revenue and Competitors
Estimated Revenue & Valuation
- Vetoquinol's estimated annual revenue is currently $368.2M per year.
- Vetoquinol's estimated revenue per employee is $201,000
Employee Data
- Vetoquinol has 1832 Employees.
- Vetoquinol grew their employee count by 4% last year.
Vetoquinol's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CMO Account Manager - Europe | Reveal Email/Phone |
2 | CEO - Directeur Général | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Head PA & CA - Commercial Directeur, AR & AC - Commercial | Reveal Email/Phone |
5 | Head Global Marketing, Strategy and Medical Affairs | Reveal Email/Phone |
6 | Head Scientific Affairs / Directrice, Affaires scientifiques | Reveal Email/Phone |
7 | head market research & prospective | Reveal Email/Phone |
8 | HR Officer, Vetoquinol Italia | Reveal Email/Phone |
9 | Head Regulatory Affairs Asia cluster, Pharmacist | Reveal Email/Phone |
10 | Head Dry Forms autonomous unit | Reveal Email/Phone |
Vetoquinol Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $284.3M | 257 | 9% | N/A | $502.4M |
What Is Vetoquinol?
With a presence amongst the top 10 global veterinary pharmaceutical laboratories, Vetoquinol is first and foremost an independent, family-owned business. Deeply committed to its values, it has always enjoyed a close relationship with its vet clients. \n\nHistorically based in France, Vetoquinol currently develops, produces and distributes a range of medical and non-medical products and services in Europe, North America and Asia-Pacific. With a presence in 24 countries through its subsidiaries, its strong network of 100 distributor partners provides visibility for its products in more than 80 countries.
keywords:N/A
N/A
Total Funding
1832
Number of Employees
$368.2M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vetoquinol News
LURE, France--(BUSINESS WIRE)-- Regulatory News: Vetoquinol (Paris: VETO) informs that it has filed its 2021 Universal Registration Document...
Vetoquinol (Paris:VETO):. Matthieu Frechin, CEO of Vetoquinol, said: "This first quarter of 2022, marked by an inflationary context, higher...
Vetoquinol is a leading global animal health company that supplies drugs and non-medicinal products for the livestock (cattle and pigs) and pet...
Veterinary pharmaceuticals company, Vetoquinol UK, has achieved bronze accreditation with Investors in the Environment (iiE), the national environmental accreditation scheme. This meaningful accolade reflects Vetoquinol's commitment to more environmentally sustainable work practices, with key ch ...
Vetoquinol (Paris: VETO) today announced that the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) has adopted a positive opinion recommending the granting of a marketing authorization of Felpreva® spot-on solution (tigolaner, emodepside, praziquantel). Felp ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $410.6M | 1833 | 5% | N/A |
#2 | $461.9M | 1833 | -4% | N/A |
#3 | $835.8M | 1837 | 0% | N/A |
#4 | $334.3M | 1837 | N/A | N/A |
#5 | $697.8M | 1846 | 1% | N/A |